Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQWE4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,110
Award facts
- Contract value 100% obligated
- $10,110.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,110.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 ml vials. The delivery order was awarded on December 1, 2025, with an ultimate completion date of December 22, 2025, and utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc. is performing the work at its Park Ridge, Illinois location and will serve as the prime contractor with no identified subcontractors involved in the delivery.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999.00 and extends through December 31, 2036, providing the DLA with the contracting mechanism to issue firm fixed-price delivery orders for branded and generic prescription medications, biologics, and medical consumables to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FQWE4?
SPE2DR26FQWE4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FQWE4 worth?
The government has obligated $10,110 on SPE2DR26FQWE4.
Is contract SPE2DR26FQWE4 an order under another contract?
Yes. SPE2DR26FQWE4 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWE4 competed?
The extent of competition for SPE2DR26FQWE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award